Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03060122 · ClinicalTrials.gov registry record · NA
Combining CES Alpha-Stim and InterX for Optimized Rehabilitation Following Extremity Immobilization
A NA study, sponsored by Brooke Army Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
NCT03060122 is a NA study that has completed, run by Brooke Army Medical Center. The registered enrollment target is 35 participants.
The verdict
NCT03060122, a NA study, has completed, sponsored by Brooke Army Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
Study Summary
This study will be aimed at assessing the feasibility of a dual-device treatment prior to a rehabilitation session for an orthopaedic injury requiring immobilization, and its impact on improving outcomes and decreasing the risk for development of neuropathic pain. The investigators will evaluate the clinical feasibility and effectiveness of incorporating the Alpha-Stim and Inter-X treatment into a standard rehabilitation protocol to address risk factors associated with the development of neuropathic pain (i.e., pain, range of motion, and skin temperature) as well as its impact on reduced pain medication.
Interventions
- DEVICE Sham CES
- DEVICE NIN
- DEVICE CES
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2018-03-01 |
| Est. Completion | 2019-08-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03060122
The ClinicalTrials.gov registry entry for NCT03060122 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brooke Army Medical Center, which has 54 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Sham CES is the first listed.
NCT03060122 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03060122 about?
NCT03060122 is a clinical study titled "Combining CES Alpha-Stim and InterX for Optimized Rehabilitation Following Extremity Immobilization". This study will be aimed at assessing the feasibility of a dual-device treatment prior to a rehabilitation session for an orthopaedic injury requiring immobilization, and its impact on improving outcomes and decreasing the risk for development of neuropathic pain. The investigators will evaluate the...
What is the current status of trial NCT03060122?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2018-03-01. Estimated completion is 2019-08-07.
What interventions are being tested in trial NCT03060122?
The interventions under investigation include: Sham CES (DEVICE), NIN (DEVICE), CES (DEVICE).
Who is sponsoring clinical trial NCT03060122?
This trial is sponsored by Brooke Army Medical Center, which has 54 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.